India Parkinsons Disorder Drugs Market (2025-2031) | Segmentation, Value, Companies, Industry, Share, Trends, Outlook, Competitive Landscape, Size & Revenue, Growth, Analysis, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Parkinsons Disorder Drugs Market Revenues & Volume, 2021 & 2031F

3.3 India Parkinsons Disorder Drugs Market - Industry Life Cycle

3.4 India Parkinsons Disorder Drugs Market - Porter's Five Forces

3.5 India Parkinsons Disorder Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 India Parkinsons Disorder Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 India Parkinsons Disorder Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of Parkinson's disease in India

4.2.2 Growing geriatric population in India

4.2.3 Rising awareness about Parkinson's disorder and available treatment options

4.3 Market Restraints

4.3.1 High cost associated with Parkinson's disorder drugs

4.3.2 Limited access to healthcare facilities in remote areas

4.3.3 Stringent regulatory requirements for drug approval in India

6.1 India Parkinsons Disorder Drugs Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 India Parkinsons Disorder Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 India Parkinsons Disorder Drugs Market Revenues & Volume, By Decarboxylase Inhibitors, 2021- 2031F

6.1.4 India Parkinsons Disorder Drugs Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.1.5 India Parkinsons Disorder Drugs Market Revenues & Volume, By Monoamine Oxidase Type B (MAO-B) Inhibitor, 2021- 2031F

6.1.6 India Parkinsons Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.2 India Parkinsons Disorder Drugs Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 India Parkinsons Disorder Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 India Parkinsons Disorder Drugs Market Revenues & Volume, By Injection, 2021- 2031F

6.2.4 India Parkinsons Disorder Drugs Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3 India Parkinsons Disorder Drugs Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 India Parkinsons Disorder Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 India Parkinsons Disorder Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.3.4 India Parkinsons Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

7.1 India Parkinsons Disorder Drugs Market Export to Major Countries

7.2 India Parkinsons Disorder Drugs Market Imports from Major Countries

8.1 Number of clinical trials for Parkinson's disorder drugs in India

8.2 Adoption rate of advanced treatment options for Parkinson's disease

8.3 Investment in research and development for new Parkinson's disorder drugs

9.1 India Parkinsons Disorder Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 India Parkinsons Disorder Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 India Parkinsons Disorder Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 India Parkinsons Disorder Drugs Market Revenue Share, By Companies, 2024

10.2 India Parkinsons Disorder Drugs Market Competitive Benchmarking, By Operating and Technical Parameters